- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier på Nevrologisk lidelse
Totalt 162045 resultater
-
Central Institute of Mental Health, MannheimHeidelberg UniversityFullførtAttention Deficit Hyperactivity DisorderTyskland
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater, Australia, Belgia, Canada, Frankrike, Tyskland, Israel, Italia, Nederland, Norge, Puerto Rico, Sør-Afrika, Sverige, Storbritannia
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKina, Taiwan, Korea, Republikken
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKorea, Republikken, Kina, Taiwan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKina, Mexico, Korea, Republikken
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTyskland
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTyskland
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderCanada
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderSverige
-
Bradley HospitalNational Institute of Mental Health (NIMH)UkjentSunn | Generalisert angstlidelse | Bipolar lidelse | Attention Deficit Disorder med hyperaktivitet | Attention Deficit Disorder uten hyperaktivitetForente stater
-
Otsuka Pharmaceutical Development & Commercialization...RekrutteringAttention Deficit/Hyperactivity DisorderForente stater
-
Otsuka Pharmaceutical Development & Commercialization...RekrutteringAttention Deficit/Hyperactivity DisorderForente stater
-
Massachusetts General HospitalRekrutteringAttention Deficit/Hyperactivity DisorderForente stater
-
Massachusetts General HospitalFullførtAttention Deficit/Hyperactivity DisorderForente stater
-
Children's Hospital Medical Center, CincinnatiRekrutteringAttention Deficit Hyperactivity DisorderForente stater
-
Bambino Gesù Hospital and Research InstituteFullførtAttention Deficit Hyperactivity DisorderItalia
-
Otsuka Pharmaceutical Development & Commercialization...FullførtAttention Deficit Hyperactivity DisorderForente stater
-
National Taiwan University HospitalFullførtAttention-deficit/Hyperactivity DisorderTaiwan
-
ShireFullførtAttention Deficit Hyperactivity DisorderSpania, Forente stater, Tyskland, Polen, Italia, Ukraina, Romania, Storbritannia, Sverige, Østerrike, Canada, Frankrike, Irland
-
ShireFullførtAttention-Deficit/Hyperactivity Disorder
-
Merck Sharp & Dohme LLCFullførtAttention Deficit Hyperactivity Disorder
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR)UkjentAttention Deficit Hyperactivity DisorderCanada
-
Hadassah Medical OrganizationFullførtAttention Deficit Hyperactivity DisorderIsrael
-
Wake Forest University Health SciencesFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Mensia Technologies SAEuropean Union H2020 SME InstrumentUkjentAttention Deficit-Hyperactivity DisorderFrankrike, Belgia, Tyskland, Spania, Sveits
-
Indiana UniversityNational Library of Medicine (NLM)FullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater, Canada, Puerto Rico
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderKorea, Republikken, Taiwan, Japan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderAustralia, Storbritannia, Mexico
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Hartford HospitalYale UniversityFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTyskland
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderItalia, Spania, Frankrike, Belgia, Tyrkia, Irland, Mexico, Norge, Storbritannia
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderTaiwan
-
Eli Lilly and CompanyFullførtAttention Deficit Hyperactivity DisorderStorbritannia
-
Centre for Addiction and Mental HealthWomen's College HospitalRekrutteringDepresjon | Attention Deficit Hyperactivity Disorder | Atferdsforstyrrelse | Opposisjonell Defiant Disorder | Atferdsproblem | Følelsesmessig problem | Forstyrrende atferdsforstyrrelseCanada
-
Hospital de Clinicas de Porto AlegreUkjentAttention Deficit/Hyperactivity DisorderBrasil
-
Kimberley LakesShireFullførtAttention Deficit/Hyperactivity DisorderForente stater
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)FullførtAttention Deficit/Hyperactivity DisorderCanada
-
Novartis PharmaceuticalsFullførtAttention Deficit/Hyperactivity DisorderTyskland, Forente stater, Belgia, Colombia, Danmark, Sverige
-
Novartis PharmaceuticalsFullførtAttention Deficit/Hyperactivity DisorderForente stater, Tyskland, Singapore, Colombia, Sverige, Belgia, Sør-Afrika, Danmark, Norge
-
University of CologneShireUkjentAttention Deficit-/Hyperactivity DisorderTyskland
-
National Taiwan University HospitalRekrutteringAttention Deficit Hyperactivity DisorderTaiwan
-
Dr. Martin A. KatzmanRekrutteringAttention Deficit Hyperactivity DisorderCanada
-
Eastern Mediterranean UniversityFullførtAttention Deficit Hyperactivity DisorderKypros
-
University of California, IrvineFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Oregon Health and Science UniversityFullførtAttention Deficit Hyperactivity DisorderForente stater